WYMZYA Fe could be initiated no before than day 28 postpartum during the nonlactating mother a result of the enhanced chance for thromboembolism. Once the tablets are administered while in the postpartum period, the enhanced threat of thromboembolic disorder affiliated with the postpartum time period needs to be deemed (see CONTRAINDICATIONS, WARNI